pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1299 |
Genomic Coordinates | chr9: 40929010 - 40929092 |
Synonyms | MIRN1299, hsa-mir-1299, MIR1299 |
Description | Homo sapiens miR-1299 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1299 | ||||||||||||||||||
Sequence | 62| UUCUGGAAUUCUGUGUGAGGGA |83 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TMPO | ||||||||||||||||||||
Synonyms | CMD1T, LAP2, LEMD4, PRO0868, TP | ||||||||||||||||||||
Description | thymopoietin | ||||||||||||||||||||
Transcript | NM_001032283 | ||||||||||||||||||||
Other Transcripts | NM_001032284 , NM_003276 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TMPO | |||||||||||||||||||||
3'UTR of TMPO (miRNA target sites are highlighted) |
>TMPO|NM_001032283|3'UTR 1 ATGGTATCTCTTTGGCACGTTCAACTTGGTCTCCTATTTTCAATAACTGTTGAAAAACATTTGTGTACACTTGTTGACTC 81 CAAGAACTAAAAATAATGTGATTTCGCCTCAATAAATGTAGTATTTCATTGAAAAGCAAACAAAATATATATAAATGGAC 161 TTCATTAAAATGTTTTTGAACTTTGGACTAGTAGGAGATCACTTTGTGCCATATGAATAATCTTTTTTAGCTCTGGAACT 241 TTTTGTAGGCTTTATTTTTTTAATGTGGGCATCTTATTTCATTTTTGAAAAAATGTATATGTTTTTTGTGTATTTGGGAA 321 ACGAAGGGTGAAACATGGTAGTATAATGTGAAGCTACACATTTAAATACTTAGAATTCTTACAGAAAAGATTTTAAGAAT 401 TATTCTCTGCTGAATAAAAACTGCAAATATGTGAAACATAATGAAATTCAGTAAGAGGAAAAGTAACTTGGTTGTACTTT 481 TTGTAACTGCAACAAAGTTTGATGGTGTTTATGAGGAAAAGTACAGCAATAATCTCTTCTGTAACCTTTATTAATAGTAA 561 TGTTGTTGTAGCCCTATCATACTCACTTTTTAAGACACAGTATCATGAAAGTCCTATTTCAGTAAGACCCATTTACATAC 641 AGTAGATTTTTAGCAGAGATCTTTTAGTGTAACATACATATTTTAGAGAATTGTTGGCTAGCTGTACATGTTTTGAAAAG 721 CTGTTTAGCTAGCTATAAGGCTATAATTGGAAATTTGTATTTTTTATTTACAGCAAAACATTTATTCAGTCATCCAGTTT 801 GCTACCAAAATATGTTTTAGATAAGTGTGTGTATGTTTGTTTAGAAGTTAGAAATTGTAAACACTGGTCTTATGTTTCAT 881 TTGGATTCATTATTGCATTGTCTTGTTACCAGAAACAAATTTTGCCGAGCTTTTTTTGCCCTATATTTCCCAGCATAATT 961 TGATTAGAAAGTACAAAAAGGGCCAGGCGCGGTGGCTTACGCCTGTAATCCCAGCACTTTGGGAGGCCAGGGCGGGTGGA 1041 TCACGAGGTCAAGAGATCAAGACCATCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAAAATTAGCTG 1121 GGCGTGATGATGTGCGCCTGTAGTCCTGTCTACTAGGGAGACTGAGGCAGGAGAATCGTTTGAACCCAGGAGGCAGAGGT 1201 TGCAGTGAGCAGAGATTACGTCACTGCACTGTAGCCTGGCGACAGAGCAAGACTCCATCTCAAAAAAAATAAAAAAGTAC 1281 AAAAAGTACTTGCTTTTATATTACATCATAAGCAGTAGTTAATAAAGTTGTATACTCTTAAGAGGTGGGCATTATGATTA 1361 TTTTTTATTTTTTTATTTTTTATGAGATGGAGTCTCACTCTTGTCACCCAGACTGTAGTGCAGTGGCACGATCTGGGCTC 1441 GATGCAACCTCTGCCTCCCAGGTTCAAGCAATTTTCCTGCCTCGGCAGAGACGGGGTTTCACCATGTTGGCCAGGCTGGT 1521 CTCGAACCCCTGACCTCAAGTGATCAGCCCACCTCAGCTTCCCAAAGTGCTGGGATTACAGGTGTGATCCACTGCACCCG 1601 GCCGGCATTATGATTTTGTGTACTCTTGAAATGGTTATCTTTGTGGATGATTTTTTTTTTTAAGCTGAAACTTACCTCAT 1681 GAATAACTTGATTAAAGTAGTAGGTGATTAAAATTTCAATAGAATCAAATGAGACAAAAATTTTAAACTGACTCATTTGA 1761 GTTTCAACTTTACAGTCATTGACCATAAAGCACACTAAAAATGTAAGTTATTTTTAAATACATCTGAAATAAAAATACTT 1841 ACTAAAAAGGAAGAAGCCGAAGATGTATATTTAGACCAGCACACAATTTTGATTTCAATTAGCCTTATTCTAATATTTAG 1921 CTTTTAGATCTTTCATACACATTTTCACGTACTTTGCAATTGAGACCAGAAAGACTTGTAGGTCTTTCTGCAGAATGAGT 2001 GGGTCCTTGCAAAGTGAGTGGGAAACTTACTCCTAGATCAGAAATGTTTGCCTCTCTGAGTAAAATGTTTCTTTCAGATG 2081 AGCCATAGAGGGGGCACCTTTTACTCAACTTTTCTTTGTTTTGAAACTTTGTTTCCCATACTGTTTTCAGCCTTTTGTTT 2161 ATAATTAGAAATTGTGAGAAGCTTCATTTAGTGTTTAAAAATGTGGGGAGATAAATCAGACTTAACATGTATGTAAGATC 2241 AATTCACTTAAAAGTATGGTCCAAATAGCAAAAATAGGACCAGGTGAAACATGTAGTCATTTTTTAAAAACATGTACTTG 2321 GTCTTTTGTGTGTGTCTGTTTTATTCCATTAGAATAAATGTGTCCTTGATGTAAATGCAAAGCATTTCTTCCTGATTAAA 2401 TTGTAGATGTAGACTTTACAATATAATTCAATAATAAAAAGTAATTAACCTCTAGTTTTGTCGTTGCAATAAATGGTTTT 2481 CAGATAGCACAAACTGTGATTTCTGGATAACATTTCTTATGAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Hela | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1048187. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_control
... - Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al. - Cell, 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [PMID: 23313552]
|
CLIP-seq Support 1 for dataset GSM1048187 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_control |
Location of target site | ENST00000266732.4 | 3UTR | UUCUGUUAAGGUUGUUUUAGUUUCCAGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
75 hsa-miR-1299 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT079552 | VAMP3 | vesicle associated membrane protein 3 | 2 | 2 | ||||||||
MIRT154885 | GNAS | GNAS complex locus | 2 | 4 | ||||||||
MIRT275056 | SESN2 | sestrin 2 | 2 | 4 | ||||||||
MIRT303051 | B3GNT2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 2 | 4 | ||||||||
MIRT319158 | CCDC71L | coiled-coil domain containing 71 like | 2 | 2 | ||||||||
MIRT339620 | TMPO | thymopoietin | 2 | 2 | ||||||||
MIRT441961 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 2 | ||||||||
MIRT445113 | DCAF4 | DDB1 and CUL4 associated factor 4 | 2 | 2 | ||||||||
MIRT445290 | CD274 | CD274 molecule | 2 | 2 | ||||||||
MIRT446037 | HMCN1 | hemicentin 1 | 2 | 2 | ||||||||
MIRT446162 | C8A | complement C8 alpha chain | 2 | 2 | ||||||||
MIRT446175 | ZNF37A | zinc finger protein 37A | 2 | 4 | ||||||||
MIRT446414 | OCA2 | OCA2 melanosomal transmembrane protein | 2 | 2 | ||||||||
MIRT446884 | TRIM25 | tripartite motif containing 25 | 2 | 2 | ||||||||
MIRT449789 | C1orf109 | chromosome 1 open reading frame 109 | 2 | 2 | ||||||||
MIRT450026 | EHD3 | EH domain containing 3 | 2 | 2 | ||||||||
MIRT450367 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 | 2 | 2 | ||||||||
MIRT479739 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT484809 | ZNFX1 | zinc finger NFX1-type containing 1 | 2 | 2 | ||||||||
MIRT485892 | ZFP36 | ZFP36 ring finger protein | 2 | 2 | ||||||||
MIRT486036 | UBBP4 | ubiquitin B pseudogene 4 | 2 | 2 | ||||||||
MIRT488295 | DHCR24 | 24-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT497377 | METTL8 | methyltransferase like 8 | 2 | 2 | ||||||||
MIRT508219 | ZNF850 | zinc finger protein 850 | 2 | 6 | ||||||||
MIRT510923 | PRRX1 | paired related homeobox 1 | 2 | 4 | ||||||||
MIRT512661 | STEAP3 | STEAP3 metalloreductase | 2 | 2 | ||||||||
MIRT520031 | YOD1 | YOD1 deubiquitinase | 2 | 6 | ||||||||
MIRT528490 | AGTR2 | angiotensin II receptor type 2 | 2 | 2 | ||||||||
MIRT530083 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | 2 | 4 | ||||||||
MIRT531086 | CCDC140 | coiled-coil domain containing 140 | 2 | 2 | ||||||||
MIRT535363 | PEX5L | peroxisomal biogenesis factor 5 like | 2 | 2 | ||||||||
MIRT535595 | NUDT21 | nudix hydrolase 21 | 2 | 2 | ||||||||
MIRT538613 | CCT5 | chaperonin containing TCP1 subunit 5 | 2 | 4 | ||||||||
MIRT539002 | AVL9 | AVL9 cell migration associated | 2 | 2 | ||||||||
MIRT545918 | ZC3H4 | zinc finger CCCH-type containing 4 | 2 | 2 | ||||||||
MIRT548482 | EEF2 | eukaryotic translation elongation factor 2 | 2 | 2 | ||||||||
MIRT555088 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT561421 | TRIB3 | tribbles pseudokinase 3 | 2 | 2 | ||||||||
MIRT564965 | WTAP | WT1 associated protein | 2 | 2 | ||||||||
MIRT571686 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | 2 | 2 | ||||||||
MIRT574656 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT610037 | CNOT6 | CCR4-NOT transcription complex subunit 6 | 2 | 6 | ||||||||
MIRT612436 | SMOC2 | SPARC related modular calcium binding 2 | 2 | 2 | ||||||||
MIRT614349 | LOH12CR1 | BLOC-1 related complex subunit 5 | 2 | 2 | ||||||||
MIRT615304 | CCDC158 | coiled-coil domain containing 158 | 2 | 2 | ||||||||
MIRT615771 | FSD2 | fibronectin type III and SPRY domain containing 2 | 2 | 2 | ||||||||
MIRT615889 | MT1A | metallothionein 1A | 2 | 2 | ||||||||
MIRT619147 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT622042 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT637385 | R3HDM2 | R3H domain containing 2 | 2 | 2 | ||||||||
MIRT640739 | EPB41 | erythrocyte membrane protein band 4.1 | 2 | 2 | ||||||||
MIRT644418 | PIGS | phosphatidylinositol glycan anchor biosynthesis class S | 2 | 2 | ||||||||
MIRT647638 | FAIM2 | Fas apoptotic inhibitory molecule 2 | 2 | 2 | ||||||||
MIRT654305 | RBMS3 | RNA binding motif single stranded interacting protein 3 | 2 | 2 | ||||||||
MIRT654367 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT655944 | NDST1 | N-deacetylase and N-sulfotransferase 1 | 2 | 2 | ||||||||
MIRT655990 | MYRF | myelin regulatory factor | 2 | 2 | ||||||||
MIRT659692 | CD226 | CD226 molecule | 2 | 2 | ||||||||
MIRT665868 | TIAF1 | TGFB1-induced anti-apoptotic factor 1 | 2 | 2 | ||||||||
MIRT667317 | MYO18A | myosin XVIIIA | 2 | 2 | ||||||||
MIRT684312 | GTF3C4 | general transcription factor IIIC subunit 4 | 2 | 2 | ||||||||
MIRT694138 | CYP27C1 | cytochrome P450 family 27 subfamily C member 1 | 2 | 2 | ||||||||
MIRT698529 | TFRC | transferrin receptor | 2 | 2 | ||||||||
MIRT698834 | SSR2 | signal sequence receptor subunit 2 | 2 | 2 | ||||||||
MIRT700657 | PPP1R11 | protein phosphatase 1 regulatory inhibitor subunit 11 | 2 | 2 | ||||||||
MIRT705377 | ATP1B3 | ATPase Na+/K+ transporting subunit beta 3 | 2 | 2 | ||||||||
MIRT707314 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT709027 | KBTBD13 | kelch repeat and BTB domain containing 13 | 2 | 2 | ||||||||
MIRT716032 | TMPRSS4 | transmembrane protease, serine 4 | 2 | 2 | ||||||||
MIRT718228 | LCE1A | late cornified envelope 1A | 2 | 2 | ||||||||
MIRT718475 | TMEM151A | transmembrane protein 151A | 2 | 2 | ||||||||
MIRT722333 | BEND6 | BEN domain containing 6 | 2 | 2 | ||||||||
MIRT734096 | TUG1 | taurine up-regulated 1 (non-protein coding) | 3 | 0 | ||||||||
MIRT734099 | NOTCH3 | notch 3 | 3 | 0 | ||||||||
MIRT755871 | LIF | LIF, interleukin 6 family cytokine | 4 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|